New Antibiotic for MRSA and PneumoniaAschenbrenner, Diane S. MS, RNAJN The American Journal of Nursing: March 2011 - Volume 111 - Issue 3 - p 23 doi: 10.1097/10.1097/01.NAJ.0000395236.76228.89 Drug Watch Abstract Author Information A new cephalosporin, ceftaroline fosamil (Teflaro), has been approved to treat acute bacterial skin infections caused by methicillin-resistant Staphylococcus aureus, as well as serious community-acquired bacterial pneumonia requiring hospitalization. Ceftaroline fosamil is administered as an IV infusion. Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: firstname.lastname@example.org. © 2011 Lippincott Williams & Wilkins, Inc.